Advertisement

Topics

TISSIUM Company Profile

23:35 EDT 22nd May 2019 | BioPortfolio

TISSIUM has taken a modular approach to product development, developing a technology platform comprised of proprietary polymers, activation technologies, and delivery devices. This modular approach has enabled TISSIUM to innovate in different therapeutic areas, and leverage the knowledge gained from the development process.


News Articles [2 Associated News Articles listed on BioPortfolio]

Gecko Biomedical Rebrands as TISSIUM

TISSIUM branding reflects broader focus on tissue reconstruction Gecko Biomedical, a privately-owned life science company developing fully synthetic, biomorphic programmable p...

TISSIUM Announces Publication in The Journal of Cardiovascular Surgery Detailing Preclinical and Clinical Evaluation of SETALIUMTM Vascular Sealant

SETALIUMTM Vascular Sealant Shown to be Safe and Effective for Vascular Reconstruction TISSIUM, a privately-owned life science company developing fully synthetic, biomo...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

TISSIUM

TISSIUM has taken a modular approach to product development, developing a technology platform comprised of proprietary polymers, activation technologies, and delivery devices. Thi...

More Information about "TISSIUM" on BioPortfolio

We have published hundreds of TISSIUM news stories on BioPortfolio along with dozens of TISSIUM Clinical Trials and PubMed Articles about TISSIUM for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TISSIUM Companies in our database. You can also find out about relevant TISSIUM Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record